MCID: NSD001
MIFTS: 48

Nose Disease malady

Categories: Respiratory diseases, Smell/Taste diseases

Aliases & Classifications for Nose Disease

Aliases & Descriptions for Nose Disease:

Name: Nose Disease 12 14
Disorder of the Nose 12 29
Nose Diseases 42 69
Nasal Disorder 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2825
MeSH 42 D009668
SNOMED-CT 64 89488007
ICD10 33 J33.9
UMLS 69 C0028432

Summaries for Nose Disease

MalaCards based summary : Nose Disease, also known as disorder of the nose, is related to marasmus and dahlberg borer newcomer syndrome, and has symptoms including dyspnea and rhinorrhea. An important gene associated with Nose Disease is RNASE3 (Ribonuclease A Family Member 3), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Allograft rejection. The drugs Amoxicillin and Cefditoren have been mentioned in the context of this disorder. Affiliated tissues include bone, and related phenotypes are Increased transferrin (TF) endocytosis and hematopoietic system

Wikipedia : 71 The visible part of the human nose is the protruding part of the face that bears the nostrils. The shape... more...

Related Diseases for Nose Disease

Diseases related to Nose Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 161)
id Related Disease Score Top Affiliating Genes
1 marasmus 10.4 IL4 IL5 RNASE3
2 dahlberg borer newcomer syndrome 10.3 IL13 IL5
3 lens-induced iridocyclitis 10.3 IL4 IL5 RNASE3
4 renal hypertension 10.3 IL13 IL5 RNASE3
5 multiple epiphyseal dysplasia due to collagen 9 anomaly 10.3 IL4 IL5 RNASE3
6 anterior dislocation of lens 10.3 CCL11 IL4 RNASE3
7 necrotizing gastritis 10.3 CCL11 IL5 RNASE3
8 bone peripheral neuroepithelioma 10.3 IL13 IL4 IL5
9 bile duct signet ring cell carcinoma 10.3 IL5 RHNO1 RNASE3
10 lactose intolerance 10.3 IL13 IL4 IL5
11 askin's tumor 10.3 IL13 IL4 IL5
12 duodenal somatostatinoma 10.3 IL13 IL4 IL5
13 alkhurma hemorrhagic fever 10.3 CD79A IL4 RHNO1
14 cutaneous ganglioneuroma 10.3 CD79A IL4 RHNO1
15 heart septal defect 10.3 CD79A RNASE3
16 tubular renal disease-cardiomyopathy syndrome 10.3 IL10 IL4
17 isthmus cancer 10.3 CCL11 CD79A IL4
18 spastic paraplegia 3a, autosomal dominant 10.3 IL13 IL4 IL5 RNASE3
19 coenurosis 10.3 CD79A IL4 IL5
20 infectious anterior uveitis 10.3 CXCL8 IL5 RNASE3
21 ovarian mucinous neoplasm 10.3 IL13 IL5 TSLP
22 luminal breast carcinoma 10.3 IL13 IL4 IL5 RNASE3
23 acute gonococcal prostatitis 10.3 IL13 IL4 IL5 RNASE3
24 psychotic disorder 10.3 CCL11 CXCL8 IL4
25 retinal vascular disease 10.3 CCL11 CXCL8 IL4
26 breast intracanalicular fibroadenoma 10.3 CXCL8 IL4 IL5
27 mesangial proliferative glomerulonephritis 10.3 CD79A CXCL8
28 lymphangiectasia, intestinal 10.3 CD79A IL4 RNASE3
29 childhood malignant mesenchymoma 10.3 CCL11 IL13 IL5 RNASE3
30 thelaziasis 10.3 CCL11 IL13 IL4 IL5
31 lymphoblastic leukemia 10.3 CCL11 IL13 IL4 IL5
32 goat milk allergy 10.3 IL10 IL13 IL4
33 wilkes stevenson syndrome 10.3 CXCL8 IL5 RNASE3
34 lymphocytic gastritis 10.3 CCL11 IL13 IL4 IL5
35 barbiturate abuse 10.3 CCL11 CD79A IL4
36 astrocytoma 10.3 IL10 IL5 RNASE3
37 malignant renovascular hypertension 10.3 CD79A TAC1
38 central nervous system origin vertigo 10.3 CD79A IL4 MS4A2 RNASE3
39 diabetic angiopathy 10.2 CD79A IL10 IL4
40 abnormal retinal correspondence 10.2 IL10 IL4 IL5
41 drug psychosis 10.2 CCL11 CD79A TAC1
42 disordered steroidogenesis due to cytochrome p450 oxidoreductase 10.2 CCL11 IL13 IL5 TSLP
43 vulvar disease 10.2 CD79A MUC5B RHNO1 RNASE3
44 spastic diplegia 10.2 CCL11 CD79A IL13 IL5
45 monocytic leukemia 10.2 CCL11 CD79A IL5 RNASE3
46 osteodysplasty precocious of danks mayne and kozlowski 10.2 CD79A IL10 IL4
47 filariasis 10.2 CD79A MUC5B RHNO1 RNASE3
48 conidiobolomycosis 10.2 CXCL8 IL10 IL4
49 tularemia 10.2 CD79A IL10 IL4
50 cutaneous fibrous histiocytoma 10.2 CCL11 IL4 IL5 PTGDR2

Graphical network of the top 20 diseases related to Nose Disease:



Diseases related to Nose Disease

Symptoms & Phenotypes for Nose Disease

UMLS symptoms related to Nose Disease:


dyspnea, rhinorrhea

GenomeRNAi Phenotypes related to Nose Disease according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased transferrin (TF) endocytosis GR00363-A 9.4 PDC PDCL PTGDR2 TAC1 CD79A CXCL8

MGI Mouse Phenotypes related to Nose Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.07 CCL11 CD79A CHD7 HRH1 ICAM1 IL10
2 homeostasis/metabolism MP:0005376 9.97 CHD7 HRH1 ICAM1 IL10 IL13 IL4
3 digestive/alimentary MP:0005381 9.87 CHD7 ICAM1 IL10 IL13 IL4 IL5
4 immune system MP:0005387 9.8 IL4 IL5 MS4A2 MUC5B PTGDR2 TSLP
5 respiratory system MP:0005388 9.28 CCL11 CHD7 CYSLTR1 IL10 IL13 IL4

Drugs & Therapeutics for Nose Disease

Drugs for Nose Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1145)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
2
Cefditoren Approved Phase 4 117467-28-4, 104145-95-1 9571074 9870843
3
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
4
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75614-87-8, 51-45-6 774
5
Capsaicin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 404-86-4 1548943
6
Montelukast Approved Phase 4,Phase 3,Phase 2,Phase 1 158966-92-8 5281040
7
Cetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1 83881-51-0 2678
8
Levocetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1 130018-77-8
9
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 10102-43-9 145068
10
Budesonide Approved Phase 4,Phase 3,Phase 2,Phase 1 51333-22-3 63006 5281004
11
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 76631-46-4, 113775-47-6 68602 5311068 56032
12
Remifentanil Approved Phase 4,Phase 3,Phase 1,Phase 2 132875-61-7 60815
13
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 2078-54-8 4943
14
Sevoflurane Approved, Vet_approved Phase 4,Phase 2 28523-86-6 5206
15
Esmolol Approved Phase 4,Phase 1,Phase 2 103598-03-4, 81147-92-4 59768
16
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
17
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
18
Heroin Approved, Illicit Phase 4,Phase 1,Phase 2 561-27-3 5462328
19
Naloxone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 465-65-6 5284596
20
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 299-42-3 9294
21
Guaifenesin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 93-14-1 3516
22
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 90-82-4 7028
23
Ketorolac Approved Phase 4,Phase 3,Phase 2,Phase 1 74103-06-3, 66635-83-4 3826
24
Norepinephrine Approved Phase 4,Phase 2,Phase 3,Early Phase 1 51-41-2 439260
25
Oxymetazoline Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1491-59-4 4636
26
Phenylephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 59-42-7 6041
27
Bromhexine Approved Phase 4 3572-43-8
28
Cyclopentolate Approved Phase 4,Phase 3,Phase 1 512-15-2 2905
29
Tropicamide Approved Phase 4,Phase 3,Phase 1 1508-75-4 5593
30
Latanoprost Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 130209-82-4 5282380 5311221
31
Alcaftadine Approved Phase 4 147084-10-4 19371515
32
Naphazoline Approved Phase 4,Phase 3 835-31-4 4436
33
Pheniramine Approved Phase 4,Phase 3 86-21-5 4761
34
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
35
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 137-58-6 3676
36
Tetracaine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 94-24-6 5411
37
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 124-94-7 31307
38
Ketamine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 6740-88-1 3821
39
Azelastine Approved Phase 4,Phase 3,Phase 2,Phase 1 58581-89-8 2267
40
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Phase 1 103-90-2 1983
41
Dextromethorphan Approved Phase 4,Phase 3,Phase 1,Phase 2 125-71-3 5360696 5362449
42
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
43
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
44
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 9004-61-9 53477741 24759
45
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-61-6, 62-31-7 681
46
Loratadine Approved Phase 4,Phase 3,Phase 2,Phase 1 79794-75-5 3957
47
Glycerol Approved, Experimental Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 56-81-5 753
48
Desloratadine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 100643-71-8 124087
49
Omalizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 242138-07-4
50
Betamethasone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 378-44-9 9782

Interventional clinical trials:

(show top 50) (show all 4073)
id Name Status NCT ID Phase
1 Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease Unknown status NCT01013701 Phase 4
2 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4
3 An Open-label Study to Identify Molecular Markers of Steroid Resistance Unknown status NCT01616160 Phase 4
4 A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children Unknown status NCT00390663 Phase 4
5 Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis Unknown status NCT01553006 Phase 4
6 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4
7 Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis Unknown status NCT02014623 Phase 4
8 Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis Unknown status NCT00825656 Phase 4
9 Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) Unknown status NCT00406094 Phase 4
10 Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais Unknown status NCT01115595 Phase 4
11 Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy Unknown status NCT01062139 Phase 4
12 Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis Unknown status NCT00488176 Phase 4
13 POLlinosis and Exhaled Breath Temperature Unknown status NCT01785394 Phase 4
14 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4
15 Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome Unknown status NCT00560586 Phase 4
16 Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites Unknown status NCT01052610 Phase 4
17 Effect of Deksmedetomidine and Remifentanil in Extubation Agitation Unknown status NCT02104297 Phase 4
18 Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy Unknown status NCT01052337 Phase 4
19 A Comparison of Esmolol and Remifentanil to Reduce Blood Loss Unknown status NCT01752959 Phase 4
20 Nasal Continuous Positive Airway Pressure (CPAP) in Chronic Fatigue and Sleep-disordered Breathing Unknown status NCT01368718 Phase 4
21 Cpap at Delivery Room for Preterm Infants Unknown status NCT01024361 Phase 4
22 Inflammatory, Functional and Image Composite Measure to Define Asthma Control Unknown status NCT00597064 Phase 4
23 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4
24 Nasal Naloxone for Narcotic Overdose Unknown status NCT01912573 Phase 4
25 Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn Unknown status NCT01499238 Phase 4
26 Comparison of Pressure Support and Pressure Control Ventilation in Chronic Respiratory Failure Unknown status NCT00994552 Phase 4
27 Two Strategies of RDS Treatment in Newborns With Birth Weight > 1500 Grams Unknown status NCT00277030 Phase 4
28 Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma Unknown status NCT01584804 Phase 4
29 Surfactant Administration During Spontaneous Breathing Unknown status NCT01329432 Phase 4
30 Comparison of the Vocal Cord Imaging Techniques After Thyroidectomy Unknown status NCT02410928 Phase 4
31 The Use of Intranasal Ketoralac for Pain Management Unknown status NCT01736358 Phase 4
32 Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients Unknown status NCT00132223 Phase 4
33 A Pilot Trial of Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients Unknown status NCT02203630 Phase 4
34 Home Oxygen Therapy in Bronchiolitis Unknown status NCT01216553 Phase 4
35 Efficacy Evaluation of Surfactant Administration Via Laryngeal Mask Airway Unknown status NCT01173237 Phase 4
36 A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold Unknown status NCT01651663 Phase 4
37 Lithium and Standard Therapy in Resistant Depression Unknown status NCT00927550 Phase 4
38 Compared Efficacy and Tolerance of Two Vasopressors Used to Treat Preoperative Hypotension During Carotid Surgery Unknown status NCT01794273 Phase 4
39 A New More Efficient Cycloplegia Scheme Unknown status NCT02177539 Phase 4
40 The Effect of "Eye Drop Guide" on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients Unknown status NCT01704248 Phase 4
41 Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma Unknown status NCT01580254 Phase 4
42 Comparison of Tolerability Between Two Allergy Drops Unknown status NCT01390961 Phase 4
43 Comparative Efficacy of 20% Benzocaine Versus TAC Alternate Gel Unknown status NCT00846690 Phase 4
44 The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine Completed NCT02477293 Phase 4
45 The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device Completed NCT02079792 Phase 4
46 Fluticasone and Salmeterol in Allergic Rhinitis Completed NCT01388595 Phase 4
47 Effect of Ketamine Addition to Lidocaine in Rhinoplasty Completed NCT01827020 Phase 4
48 Evaluation Of Cloumella Strut Effect In Tip Rotation Completed NCT00467714 Phase 4
49 Neuro-immunological Analysis of Idiopathic Rhinitis Patients and Controls Treated With Capsaicin. Completed NCT01223820 Phase 4
50 Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and Controls Completed NCT01862523 Phase 4

Search NIH Clinical Center for Nose Disease

Cochrane evidence based reviews: nose diseases

Genetic Tests for Nose Disease

Genetic tests related to Nose Disease:

id Genetic test Affiliating Genes
1 Abnormality of the Nose 29

Anatomical Context for Nose Disease

MalaCards organs/tissues related to Nose Disease:

39
Bone

Publications for Nose Disease

Articles related to Nose Disease:

id Title Authors Year
1
Blue nose disease in the horse. ( 18124494 )
1949

Variations for Nose Disease

Expression for Nose Disease

Search GEO for disease gene expression data for Nose Disease.

Pathways for Nose Disease

Pathways related to Nose Disease according to GeneCards Suite gene sharing:

(show all 23)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.27 CCL11 CXCL8 ICAM1 IL10 IL13 IL4
2
Show member pathways
12.55 CCL11 CXCL8 ICAM1 IL10 IL13 IL4
3
Show member pathways
12.51 CD79A IL13 IL4 IL5 MS4A2
4
Show member pathways
12.32 CCL11 CXCL8 IL13 IL4 IL5 MUC5B
5
Show member pathways
12.2 IL10 IL13 IL4 IL5 TSLP
6
Show member pathways
12.14 CXCL8 IL10 IL13 IL4 IL5
7 12.11 CXCL8 IL10 IL13 TAC1
8 11.99 CD79A IL10 IL4 IL5 PTGDR2
9 11.79 CCL11 CXCL8 ICAM1 IL10 IL13 IL4
10 11.74 CXCL8 ICAM1 IL13 IL4 IL5
11 11.72 ICAM1 IL10 IL4 IL5
12
Show member pathways
11.66 CXCL8 IL4 IL5
13 11.65 CCL11 IL10 IL4 IL5
14 11.46 CXCL8 ICAM1 IL10
15 11.46 CXCL8 ICAM1 IL10 IL13 IL4
16 11.39 CCL11 IL10 IL13 IL4 IL5
17 11.34 IL10 IL13 IL4 IL5 PTGDR2 TSLP
18 11.3 IL13 IL4 IL5 TSLP
19 11.26 IL10 IL13 IL4 IL5
20 11.16 CCL11 CXCL8 IL10 IL13 IL4 IL5
21 11.12 IL10 IL13 IL4 IL5
22 10.91 IL13 IL4 IL5
23 10.9 CCL11 CXCL8 IL13 IL4 IL5 MUC5B

GO Terms for Nose Disease

Cellular components related to Nose Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.85 CCL11 CXCL8 IL10 IL13 IL4 IL5
2 extracellular space GO:0005615 9.36 CCL11 CXCL8 ICAM1 IL10 IL13 IL4
3 external side of plasma membrane GO:0009897 9.35 CD79A ICAM1 IL13 IL4 MS4A2

Biological processes related to Nose Disease according to GeneCards Suite gene sharing:

(show all 22)
id Name GO ID Score Top Affiliating Genes
1 response to lipopolysaccharide GO:0032496 9.81 ICAM1 IL10 IL13 TAC1
2 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.77 ICAM1 IL4 IL5
3 cellular response to interleukin-1 GO:0071347 9.74 CCL11 CXCL8 ICAM1
4 B cell differentiation GO:0030183 9.72 CD79A IL10 IL4
5 chemotaxis GO:0006935 9.65 CCL11 CXCL8 CYSLTR1 IL4 PTGDR2
6 microglial cell activation GO:0001774 9.61 IL13 IL4
7 negative regulation of nitric oxide biosynthetic process GO:0045019 9.59 IL10 IL4
8 response to molecule of bacterial origin GO:0002237 9.58 CXCL8 IL10
9 positive regulation of macrophage activation GO:0043032 9.58 IL10 IL13
10 positive regulation of mast cell degranulation GO:0043306 9.56 IL13 IL4
11 immune response GO:0006955 9.56 CCL11 CXCL8 IL10 IL13 IL4 IL5
12 eosinophil chemotaxis GO:0048245 9.54 CCL11 HRH1
13 positive regulation of B cell proliferation GO:0030890 9.54 IL13 IL4 IL5
14 positive regulation of MHC class II biosynthetic process GO:0045348 9.52 IL10 IL4
15 positive regulation of immunoglobulin production GO:0002639 9.49 IL13 IL4
16 queuosine biosynthetic process GO:0008616 9.48 PDC PDCL
17 type 2 immune response GO:0042092 9.46 IL10 IL4
18 negative regulation of endothelial cell apoptotic process GO:2000352 9.46 ICAM1 IL10 IL13 IL4
19 regulation of isotype switching GO:0045191 9.43 IL10 IL4
20 regulation of proton transport GO:0010155 9.4 IL13 IL4
21 negative regulation of complement-dependent cytotoxicity GO:1903660 9.32 IL13 IL4
22 inflammatory response GO:0006954 9.23 CCL11 CXCL8 HRH1 IL10 IL13 IL5

Molecular functions related to Nose Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.17 CCL11 CXCL8 IL10 IL13 IL4 IL5
2 queuine tRNA-ribosyltransferase activity GO:0008479 8.96 PDC PDCL

Sources for Nose Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....